U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a new federal initiative to build a comprehensive autism data platform using Medicare and Medicaid records. Designed to study the causes of autism spectrum disorder (ASD), the platform will integrate claims data, electronic health records, and data from wearable health devices, according to the Department of Health and Human Services (HHS).
The National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) will collaborate on the effort, which is part of a broader $50 million research initiative to investigate potential environmental and medical causes of autism. Kennedy stated the project aims to provide "honest answers families have waited far too long to hear," despite his controversial history promoting a debunked link between vaccines and autism.
HHS said the platform will help researchers analyze autism diagnoses, treatment outcomes, healthcare access disparities, and the financial impact on families. However, experts like Dr. Helen Tager-Flusberg of Boston University argue the focus does not directly address autism’s root causes. She also noted that an existing NIH autism database recently went offline without explanation, raising concerns about transparency.
The project has sparked privacy questions, as HHS has not confirmed whether the database will be anonymous or voluntary. Autism researcher Eric Rubenstein noted that Medicaid and Medicare data offer insights into health disparities but lack environmental exposure data, which Kennedy claims he will explore.
Autism rates have surged in recent years, with the CDC reporting 1 in 31 U.S. 8-year-olds diagnosed in 2022. While Kennedy aims to identify autism’s causes by September, scientists emphasize that autism likely stems from a complex mix of genetic and environmental factors. Critics warn against oversimplifying this ongoing scientific challenge.


FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Taiwan Opposition Criticizes Plan to Block Chinese App Rednote Over Security Concerns
Trump Administration Fuel-Efficiency Rollback Could Raise Long-Term Costs for U.S. Drivers
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Trump Signs Executive Order to Strengthen U.S. Food Supply Chain Security
DOJ Sues Loudoun County School Board Over Transgender Locker Room Policy
Trump Set to Begin Final Interviews for Next Federal Reserve Chair
CFPB to Review Anti-Discrimination Policies and Fair Lending Rules Amid Policy Shift
Southwest Airlines Has $11 Million Fine Waived as USDOT Cites Operational Improvements
Australia’s Under-16 Social Media Ban Sparks Global Debate and Early Challenges
China Adds Domestic AI Chips to Government Procurement List as U.S. Considers Easing Nvidia Export Curbs
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Australia Pushes Forward on AUKUS Submarine Program Amid Workforce and Production Challenges 



